文献速递母胎医学生殖医学

「我可以信任它」:相互易位携带者及其伴侣对产前无创DNA筛查不平衡易位的体验

'I Could Trust It': Experiences of Reciprocal Translocation Carriers and Their Partners With Prenatal Cell-Free DNA Screening for Unbalanced Translocations.
PubMed 文献 · Prenat Diagn · 2024-11-06

该定性研究通过半结构化访谈,探讨相互易位携带者及其伴侣接受cfDNA筛查检测不平衡易位的体验与选择动机。13名参与者在2015至2019年间经维多利亚临床遗传学服务接受cfDNA筛查,分析显示其选择cfDNA筛查而非产前诊断以避免妊娠风险,并因早孕期获得结果而有足够信心拒绝诊断性检测。作者认为cfDNA筛查可作为产前诊断的可接受替代方案,应更易获取,并需提供专业遗传咨询。

要点

  • 参与者选择cfDNA筛查而非产前诊断,以避免对妊娠的风险
  • 参与者受益于早孕期获得结果,并对结果有足够信心拒绝诊断性检测
  • 作者认为cfDNA筛查是产前诊断的可接受替代方案,应更易获取

核心结论

  • 参与者的cfDNA筛查体验与作为相互易位携带者的体验交织在一起
  • cfDNA筛查检测不平衡易位被视为产前诊断的可接受替代方案,应使平衡易位携带者更易获取
  • 需要专业遗传咨询服务以确保夫妇获得所有产前检测选项的信息,包括cfDNA筛查检测不平衡易位的益处与局限性

研究设计与样本

  • 采用定性方法,对相互易位携带者及其伴侣进行深度半结构化访谈
  • 2015年至2019年间通过维多利亚临床遗传学服务接受cfDNA筛查并分析易位的人群被邀请参与
  • 基于参与者地理位置、转诊医生专业和cfDNA筛查结果进行目的性抽样,以获取不同体验
  • 访谈转录采用主题分析
  • 参与者共13名

主要发现

  • 参与者与易位相关的生殖历程复杂,选择cfDNA筛查而非产前诊断以避免对妊娠的风险
  • 参与者受益于早孕期获得结果,并对结果有足够信心拒绝诊断性检测程序

临床怎么用

  • 作者认为cfDNA筛查检测不平衡易位是产前诊断的可接受替代方案,应使平衡易位携带者更易获取
  • 作者指出需要专业遗传咨询服务以确保夫妇获得所有产前检测选项的信息,包括cfDNA筛查检测不平衡易位的益处与局限性

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To explore the experiences of people having cfDNA screening to detect unbalanced translocations, and to understand motivations for choosing this option. METHODS: We used a qualitative approach with in-depth semi-structured interviews with reciprocal translocation carriers and their partners. People who underwent cfDNA screening with translocation analysis through Victorian Clinical Genetics Services between 2015 and 2019 were invited to take part. Purposive sampling based on the participant's geographic location, requesting practitioner specialty and cfDNA screening result was used to capture a range of experiences. Interview transcripts were analysed using thematic analysis. RESULTS: Participants (n = 13) had complex reproductive journeys associated with the translocation and opted for cfDNA screening rather than prenatal diagnosis to avoid risk to their pregnancy. Participants benefited from having a result early in pregnancy and had sufficient confidence in the result to decline a diagnostic testing procedure. CONCLUSION: Participants' experiences with cfDNA screening were intertwined with the experience of being a carrier of a reciprocal translocation. cfDNA screening with translocation analysis was perceived as an acceptable alternative to prenatal diagnosis and should be made more accessible to balanced translocation carriers. Access to specialist genetic counselling services is needed to ensure couples are provided with information about all prenatal testing options, including the benefits and limitations associated with cfDNA screening with translocation analysis.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Cifuentes Ochoa M, Archibald AD, Flowers NJ, et al. 'I Could Trust It': Experiences of Reciprocal Translocation Carriers and Their Partners With Prenatal Cell-Free DNA Screening for Unbalanced Translocations. Prenat Diagn. 2024. PMID: 39505709. doi:10.1002/pd.6696

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。